Home
About
Overview
Sharing Data
ORCID
Help
History (2)
HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
Regulatory cohesion of cell cycle and cell differentiation through interlinked phosphorylation and second messenger networks.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
Moonis M, Fisher M. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke. Expert Rev Neurother. 2004 Mar; 4(2):241-7.
View in:
PubMed
subject areas
Animals
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Randomized Controlled Trials as Topic
Stroke
Treatment Outcome
authors with profiles
Majaz Moonis MD